Literature DB >> 20049516

Investigating the function of three non-synonymous SNPs in EGFR gene: structural modelling and association with breast cancer.

Mouna Choura1, Fakher Frikha, Najla Kharrat, Sami Aifa, Ahmed Rebaï.   

Abstract

Non-synonymous single nucleotide polymorphisms (nsSNPs) represent common genomic variations that alter protein sequence and function. Some nsSNPs affecting conserved amino acids have been reported to be associated with cancer susceptibility. Interestingly, Epidermal Growth Factor Receptor (EGFR) is commonly overexpressed and mutated in many cancers. In this study, we investigated the structural effect of three deleterious nsSNPs: rs17337451 (R962G), rs1140476 (R977C) and rs17290699 (H988P) within EGFR using computational tools. The modelled mutant dimers showed less stability than wild type EGFR dimer. Furthermore, we showed the important role of R962 and H988 residues in the EGFR dimer formation. We also report preliminary experimental data for SNP R977C suggesting that the variant C977 might confer greater risk for breast cancer. These results contribute to an improved understanding of the EGFR dimer stability and provide new elements for understanding the relationship between EGFR and cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049516     DOI: 10.1007/s10930-009-9221-0

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  12 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

Authors:  N Prenzel; O M Fischer; S Streit; S Hart; A Ullrich
Journal:  Endocr Relat Cancer       Date:  2001-03       Impact factor: 5.678

3.  Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery.

Authors:  Santiago Vilar; Giorgio Cozza; Stefano Moro
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

4.  Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.

Authors:  Najla Kharrat; Suad Al'Fadhli; Ahmed Rebaï
Journal:  J Recept Signal Transduct Res       Date:  2008       Impact factor: 2.092

5.  An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.

Authors:  Xuewu Zhang; Jodi Gureasko; Kui Shen; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

6.  Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.

Authors:  Sami Aifa; Nabil Miled; Fakher Frikha; Mohamed R Aniba; Samuel P S Svensson; Ahmed Rebai
Journal:  Proteins       Date:  2006-03-01

Review 7.  ErbB antagonists patenting: "playing chess with cancer".

Authors:  Sami Aifa; Ahmed Rebai
Journal:  Recent Pat Biotechnol       Date:  2008

Review 8.  Why the epidermal growth factor receptor? The rationale for cancer therapy.

Authors:  José Baselga
Journal:  Oncologist       Date:  2002

9.  Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

Authors:  Jennifer Stamos; Mark X Sliwkowski; Charles Eigenbrot
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

10.  Applications of computational tools to predict functional SNPs effects in human ErbB genes.

Authors:  Mouna Choura; Ahmed Rebaï
Journal:  J Recept Signal Transduct Res       Date:  2009       Impact factor: 2.092

View more
  5 in total

1.  Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

Authors:  Jia Wu; Wei Zhang; Aiqiang Xu; Li Zhang; Tao Yan; Zhuo Li; Xiaopan Wu; Xilin Zhu; Juan Ma; Ke Li; Hui Li; Ying Liu
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-22

2.  Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Richard N Baumgartner; Kathy B Baumgartner; Christina M Pinkston; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2013-11-28

3.  EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Authors:  Wenfang Yao; Duiping Feng; Weihua Bian; Longyan Yang; Yang Li; Zhiyu Yang; Ying Xiong; Junfang Zheng; Renyou Zhai; Junqi He
Journal:  Amino Acids       Date:  2012-04-04       Impact factor: 3.520

4.  An In Silico Evaluation of Deleterious Nonsynonymous Single Nucleotide Polymorphisms in the ErbB3 Oncogene.

Authors:  Dhwani Raghav; Vinay Sharma
Journal:  Biores Open Access       Date:  2013-06

5.  The impact of EGFR gene polymorphisms on the response and toxicity derived from neoadjuvant chemotherapy for breast cancer.

Authors:  Yan Wang; Ziping Wu; Liheng Zhou; Jinglu Lu; Yaohui Wang; Yanping Lin; Shuguang Xu; Yumei Ye; Jing Peng; Jie Zhang; Wenjin Yin; Jinsong Lu
Journal:  Gland Surg       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.